Mallinckrodt Pharmaceuticals - Exhibitor



Company Website

Contact Information:
Denise Bentley
denise.bentley@mnk.com
980-445-6163

Jessica Hargrove
Jessica.Hargrove@mnk.com
573-355-2667
 

Virtual Exhibit Hall Home

 

Kidneys Can't Wait

The latest ICA consensus recommendations eliminate a serum creatinine (SCr) threshold for the diagnosis of HRS-1.1
The application of these recommendations enabled:
• Earlier treatment by approximately 4 days2
• Initiation of treatment when SCr levels were, on average, approximately 1 mg/dL lower2
• Treatment before a further ≥1.5-fold increase in SCr (in 47% of patients)2

1. Angeli P, Ginès P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64(4):531-537.
2. Wong F, Pappas SC, Vargas HE, Frederick RT, Sanyal A, Jamil K. Diagnosis of hepatorenal syndrome (HRS): how much does use of the 2015 revised consensus recommendations affect earlier treatment and serum creatinine (SCr) at treatment start? Poster presented at: International Liver Congress™ of the European Association for the Study of the Liver; April 10-14, 2019; Vienna, Austria. Poster SAT-141.
Additional Information:
HRS-1 Diagnosis and Treatment Algorithm